CanNordic a/s: Financial statements 2022
CVR: 33871902
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
CanNordic a/s (CVR 33871902) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 502,674 and a net result of DKK -4,299,257 compared with DKK 1,480,251 the year before. That is a decrease of 79.4% compared with the year before. Equity in the 2022 report amounted to DKK 640,767. The solvency ratio was 3%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 502,674
- Profit/Loss
- DKK -4,299,257
- Equity
- DKK 640,767
- Total Assets
- DKK 21,373,261
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 503 t. | -4.3 mio. | 641 t. | 5 |
| 2021 | 3.2 mio. | 2.4 mio. | 1.5 mio. | 1.9 mio. | 4 |
| 2020 | - | 775 t. | -46 t. | 47 t. | 2 |
| 2019 | - | 211 t. | -178 t. | -1.8 mio. | - |
| 2018 | - | 579 t. | 200 t. | -1.6 mio. | - |
Official annual report
Keep an eye on CanNordic a/s
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of October 25, 2022, Bo Erik Lennart Unéus has left the board of directors of CanNordic a/s.
As of February 9, 2022, Alexandre Fevre has joined the board of directors of CanNordic a/s.
CanNordic a/s has published its annual report for 2021. Revenue came to DKK 3,156,907, and the net result was DKK 1,480,251.
About CanNordic a/s
CanNordic a/s is a Danish company of the type Aktieselskab based in København Ø, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named GALAXA PHARMA ApS. The management consists of Lone Henriksen. The board consists of Gitte Henriksen, Jens Jørgen Hagelskjær and Lone Henriksen. The company is owned by CS MEDICA a/s. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK -100,395 and a net result of DKK -6,219,720 compared with DKK -4,881,640 the year before. Equity in the 2025 report amounted to DKK 4,298,968.
